Biopharma Comebacks With Vincerx's Ahmed Hamdy, MD
Business Of Biotech
00:00
The FDA and the Regulative Scene in Biopharmacy
The FDA and the regulatory body are ensuring that you find your minimal efficacious dose and your optimal dose and profile. Now, cancer is being treated as a chronic disease. So we need to design trials,. thinking of the long term effect, thinking of what is the minimal efficacious doses. And if you design your trials very early on, you're going to be able to get to the point where like you said, win but it's actually getting drugs out of patients.
Transcript
Play full episode
